Coronary Artery Disease and Sleep Apnea

This study has been completed.
Sponsor:
Collaborators:
Swedish Heart Lung Foundation
Norrländska Hjärtfonden
Jämtland County Council, Sweden
Information provided by:
Umeå University
ClinicalTrials.gov Identifier:
NCT00562679
First received: November 21, 2007
Last updated: July 1, 2008
Last verified: June 2008
  Purpose

The purpose of this study is to determine the effect of sleep apnea on mortality, stroke and myocardial infarction among 408 patients with coronary artery disease referred for evaluation of coronary intervention who were examined with overnight cardio respiratory monitoring between March 1992 and June 1995.


Condition Intervention
Coronary Artery Disease
Other: There is no intervention

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Long Term Effects of Sleep Apnea in Patients With Coronary Artery Disease

Resource links provided by NLM:


Further study details as provided by Umeå University:

Primary Outcome Measures:
  • Stroke, death, acute myocardial infarction [ Time Frame: 10 years from date of inclusion ]

Enrollment: 408
Study Start Date: March 1992
Study Completion Date: October 2007
Groups/Cohorts Assigned Interventions
2 groups
The cohort is grouped according to one group with sleep apnea and one group without sleep apnea
Other: There is no intervention
not applicable

  Eligibility

Ages Eligible for Study:   up to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patiens with coronary artery disease beeing referred for evaluation of coronary intervention

Criteria

Inclusion Criteria:

  • Men and women younger than 70 with disabling angina pectoris and coronary disease according to coronary angiography.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00562679

Locations
Sweden
Dept of Cardiology
Umeå, Sweden, SE 901 85
Sponsors and Collaborators
Umeå University
Swedish Heart Lung Foundation
Norrländska Hjärtfonden
Jämtland County Council, Sweden
Investigators
Principal Investigator: Thomas Mooe, MD, PhD Dept Medicine, Östersund Hospital, Östersund
  More Information

No publications provided by Umeå University

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00562679     History of Changes
Other Study ID Numbers: 93-032
Study First Received: November 21, 2007
Last Updated: July 1, 2008
Health Authority: Sweden: The National Board of Health and Welfare

Keywords provided by Umeå University:
Patients with coronary artery disease

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Heart Diseases
Cardiovascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on October 19, 2014